Viewing Study NCT07181369

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-02-01 @ 10:41 PM
Study NCT ID: NCT07181369
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-09-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Cold Urticaria
Sponsor: Granular Therapeutics Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Subjects View
None Cold Urticaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urticaria View
None Skin diseases View
None Mast cells View
None Bispecific antibody View
None GTX-B001 View
None Infusion View
None Single Ascending Dose View
None Healthy subjects View
None Safety View
None Pharmacokinetics View
None Pharmacodynamics View
None Cold urticaria View
None Intravenous View